WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,622 Cr | ₹2,042 Cr | ₹2,791 Cr | ₹3,435 Cr | ₹3,207 Cr |
What is the latest Total Current Liabilities ratio of WOCKHARDT ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,622 Cr |
| Mar2025 | ₹2,042 Cr |
| Mar2024 | ₹2,791 Cr |
| Mar2023 | ₹3,435 Cr |
| Mar2022 | ₹3,207 Cr |
How is Total Current Liabilities of WOCKHARDT Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,622 Cr | -20.57 | |
| Mar2025 | ₹2,042 Cr | -26.84 | |
| Mar2024 | ₹2,791 Cr | -18.75 | |
| Mar2023 | ₹3,435 Cr | 7.11 | |
| Mar2022 | ₹3,207 Cr | - | |
Compare Total Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,117.9 Cr | -5.2% | 1.2% | 25.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -5.2% |
1.2% |
25.1% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses